Ana Bouchet is the Co-founder and CEO of Lifesome Therapeutics. She holds a degree in Biotechnology and a PhD in Lipid Biophysics. Her research interests include nanotechnology, molecular delivery, and biophysics applied to biomaterials. In 2022, she spearheaded the company’s growth by leading the company’s acceleration strategy. She also completed studies in Innovation Management at IESE Business School, bridging the gap between her scientific expertise in biophysics and its translation into the biotech industry.
